ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[한국경제] “혈액암 환자에 CAR-T 투여기간 4분의 1로 줄였죠”
2023/08/15
혈액암 환자에 CAR-T 투여기간 4분의 1로 줄였죠 | 한국경제 (hankyung.com)
한국경제 김유림 기자
Prev
큐로셀, 성인 급성림프구성백혈병 CAR-T 치료제 임상시험 첫 환자 투여완료
Next
CAR-T 치료제 전문 기업 큐로셀, 상장 예비심사 통과
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
